Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
rhIKK-1/rhIKK-2 heterodimer
CAS Number: 1414854-42-4
5-3(6)1-2-4(7)8/h2-3
CAS Number: 2446474-09-3
and marketed as Nimbex) is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs
Oclacitinib - CAS# 1208319-26-9 Catalog No.:M9848-2 rhIKK-1/rhIKK-2 heterodimerOclacitinib, also known as PF03394197, is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 's) ranging from 10 to 99 nM and did not inhibit a panel of 38 non JAK kinases (IC50 's > 1000 nm). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nm). Oclacitinib also inhibited the function of JAK1 dependent cytokines involved in allergy and
US$ 26.00
US$ 29.99
US$ 14.00
US$ 135.00
US$ 105.00
US$ 75.00
US$ 2460.31
US$ 3517.64
US$ 3655.45
US$ 120.00
US$ 55.00
US$ 1810.06
US$ 2154.37
US$ 90.00